{Reference Type}: Journal Article
{Title}: Exploring non-viral methods for the delivery of CRISPR-Cas ribonucleoprotein to hematopoietic stem cells.
{Author}: Molaei Z;Jabbarpour Z;Omidkhoda A;Ahmadbeigi N;
{Journal}: Stem Cell Res Ther
{Volume}: 15
{Issue}: 1
{Year}: 2024 Jul 29
{Factor}: 8.079
{DOI}: 10.1186/s13287-024-03848-4
{Abstract}: Gene manipulation of hematopoietic stem cells (HSCs) using the CRISPR/Cas system as a potent genome editing tool holds immense promise for addressing hematologic disorders. An essential hurdle in advancing this treatment lies in effectively delivering CRISPR/Cas to HSCs. While various delivery formats exist, Ribonucleoprotein complex (RNP) emerges as a particularly efficient option. RNP complexes offer enhanced gene editing capabilities, devoid of viral vectors, with rapid activity and minimized off-target effects. Nevertheless, novel delivery methods such as microfluidic-based techniques, filtroporation, nanoparticles, and cell-penetrating peptides are continually evolving. This study aims to provide a comprehensive review of these methods and the recent research on delivery approaches of RNP complexes to HSCs.